Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 2006, p. 1376-1381, Vol. 44, No. 4
0095-1137/06/$08.00+0 doi:10.1128/JCM.44.4.1376-1381.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Microbiology II, Hiroshima Prefectural Institute of Public Health and Environment, Hiroshima 734-0007, Japan
Received 22 November 2005/ Returned for modification 24 December 2005/ Accepted 26 January 2006
|
|
|---|
|
|
|---|
Recently, the detection of NoV genomes by nucleic acid sequence-based amplification (NASBA) (6, 9, 15) as an isothermal amplification method was reported, and similarly, a transcription-reverse transcription concerted (TRC) assay (8) for the detection of NoV genomes has been commercially developed in Japan. As another isothermal amplification method, the loop-mediated isothermal amplification (LAMP) assay developed by Notomi et al. (18) is a simple method for genome diagnostics and has the advantages of high specificity and selectivity. Six primers containing two loop primers in an RT-LAMP assay are required for rapid and sensitive detection of RNA. Although more primers are needed in the RT-LAMP assay than in other amplification methods, the RT-LAMP assay has recently been applied for the rapid detection of several RNA viruses in humans, such as West Nile virus (23), severe acute respiratory syndrome coronavirus (22, 25), influenza A virus (21), mumps virus (19), measles virus (4), dengue virus (20), and respiratory syncytial virus (26).
Because the NoVs are classified into two genogroups (GI and GII) and further divided into 14 genotypes in GI and 17 genotypes in GII according to the scheme of Kageyama et al. (10), it has been thought likely that the design of consensus primers for many genotypes of NoVs might be difficult.
In this study, we developed a genogroup-specific RT-LAMP assay for detecting NoV genomes using multiple primers containing mixed bases.
|
|
|---|
Viral RNA extraction. The viral RNA was extracted from 140 µl of the supernatant of approximately 10% fecal specimens with a QIAamp viral RNA mini kit (QIAGEN, Valencia, CA). The extracted RNAs were kept at 80°C until use in tests.
Primer design. The NoV-specific primers were designed on the basis of the sequence of the region from the C terminus of the RNA-dependent RNA polymerase gene to the capsid N-terminal/shell domain region, and two sets of genogroup-specific primers for GI and GII were designed. For GI, the nine primers consisted of two outer primers (F3 and B3), four inner primers (FIP1, FIP2, BIP1, and BIP2), and three forward loop primers (LF1, LF2, and LF3). For GII, the 13 primers consisted of two outer primers (F3 and B3), seven inner primers (FIP1, FIP2, FIP3, BIP1, BIP2, BIP3, and BIP4), and four forward loop primers (LF1, LF2, LF3, and LF4). FIP contain F1C, a TTTT spacer, and F2, and BIP contain B1C, a TTTT spacer, and B2. The B3 reverse outer primers for GI and GII were the G1SKR and G2SKR primers, respectively, as described elsewhere (13). The FIP and BIP primers were high-performance liquid chromatography-purified primers, and the others were oligonucleotide purification cartridge-purified primers. The sequences and locations of the oligonucleotide primers are shown in Table 1 and Fig. 1.
|
View this table: [in a new window] |
TABLE 1. Primer sets for genogroups I and II for detection of noroviruses
|
![]() View larger version (81K): [in a new window] |
FIG. 1. Location of primers used for genogroup I (A) and II (B) for genogroup-specific RT-LAMP assay. (A) Sequence of Norwalk/68/US (GenBank accession number M87661); (B) sequence of Lordsdale/93/UK (X86557). Numbers at the beginning and end of the sequences denote nucleotide positions. Primers FIP and BIP in Table 1 consist of F1C plus TTTT plus F2 and B1C plus TTTT plus B2, respectively, where TTTT is a spacer. The B3 primers for genogroups I and II were primers G1SKR and G2SKR, respectively, as described by Kojima et al. (13).
|
0.1 was considered positive. For measuring the detection limit of the RT-LAMP assay, the samples were tested in triplicate and the lowest concentration of genome copies was taken as the limit when all of the triplicate samples were positive. In addition, the fecal specimens that gave positive results at over 60 min were retested another time. Then, 2 µl of the amplified product from the RT-LAMP assay was electrophoresed on a 3% agarose gel in Tris-acetate-EDTA buffer, stained with ethidium bromide, and visualized under UV light, when necessary. RT-PCR and real-time quantitative PCR. A conventional RT-PCR was performed to compare with the sensitivity of the RT-LAMP assay. The RT was first performed in 20 µl of a mixture containing 50 pmol of random nonamer [pd(N)9; Takara Bio, Shiga, Japan], 20 U of RNase inhibitor (TOYOBO, Osaka, Japan), 100 U of reverse transcriptase (ReverTra Ace; TOYOBO), 2.5 mM concentrations of each deoxynucleoside triphosphate, and 9.5 µl of RNA extract. The RT conditions were 30°C for 10 min and then 42°C for 60 min, followed by 99°C for 5 min. After RT, PCR was performed in 50 µl of a reaction mixture containing 0.25 U of Ex Taq DNA polymerase (Takara), 2.5 mM concentrations of each deoxynucleoside triphosphate, 10 pmol (each) of primers G1SKF and G1SKR for GI or G2SKF and G2SKR for GII, as previously described (13), and 3 µl of cDNA.
For the measurement of the number of genome copies in the RT-LAMP-positive samples, real-time quantitative PCR was performed by using primers COG1F and COG1R and fluorogenic probe RING1-TP(a) for GI and primers COG2F and COG2R and fluorogenic probe RING2-TP for GII (11) with a LightCycler (Roche Diagnostics, Penzberg, Germany). The real-time PCR was performed in 20 µl of a reaction mixture containing 2 µl of 10x PCR master mix (LC FastStart DNA hybridization probes; Roche), 10 pmol of each of the primers, 8 pmol fluorogenic probe, 3 mM MgCl2, and 5 µl of cDNA. The following real-time PCR conditions were used: 95°C for 10 min, 50 cycles of 95°C for 15 s, 56°C for 20 s, and 72°C for 4 s, and a final cooling at 40°C for 30 s.
Standard RNA. The plasmid DNAs containing the target sequences amplified with primer sets F3 and B3 (G1SKR) for GI or F3 and B3 (G2SKR) for GII were first prepared with the pDrive cloning vector (QIAGEN). The standard RNAs were transcribed from the plasmid DNAs by using SP6 polymerase (Ambion, Austin, TX) and were used to determine the sensitivity of the RT-LAMP assay. The standard RNAs for GI and GII belonged to genotypes GI/2 and GII/12, respectively, according to the scheme of Kageyama et al. (10).
Genotyping. After purification of the RT-PCR-positive products with a QIAquick PCR purification kit (QIAGEN), the sequencing of 260 bp was carried out with a SequiTherm EXCEL II DNA sequencing kit LC for 25- to 41-cm gels (EPCENTRE Technologies, Madison, WI) and a LI-COR 4200 series sequencer (LI-COR, Lincoln, NE). The sequences were compared with those of the reference strains of NoVs obtained from GenBank and classified into 31 genotypes as described by Kageyama et al. (10).
|
|
|---|
Sensitivity and specificity of the RT-LAMP assay. The sensitivity of the RT-LAMP assay for the detection of NoV genomes was tested by using serial 10-fold dilutions of standard RNAs of GI and GII with Easy Dilution solution (Takara) and compared with that of conventional RT-PCR. The detection limits of the RT-LAMP assay for the standard RNAs of GI and GII were found to be approximately 102 and 103 copies/tube, with a time of positive change of 57 to 65 min (average, 61 min) and 57 to 60 min (average, 59 min), respectively, which were the same as for the turbidity assay, but 10-fold less reactivity than that of RT-PCR was observed (Fig. 2). A positive reaction in the RT-LAMP assay was seen as a ladder-like pattern in 3% agarose gel electrophoresis analysis. No cross-reaction was found between GI and GII with the standard RNAs of genotypes GI/2 and GII/12 at 108 copies/tube, respectively. Graphs of the data obtained for real-time amplification in the RT-LAMP assay are shown in Fig. 3. The times until positive change were found to be 31 min for genotype GI/2 and 20 min for GII/12. Furthermore, serial 10-fold dilutions of RNA extracts prepared from the fecal specimens were used to determine the sensitivity of the RT-LAMP assay according to genotype. For GI, the sensitivities of genotypes GI/1, GI/2, GI/4, GI/8, GI/11, and GI/14 tested were 102, 102, 102, 102, 102, and 103 copies/tube, respectively, in the turbidity assay. For GII, the sensitivities of genotypes GII/1, GII/2, GII/3, GII/4, GII/5, GII/6, GII/8, GII/12, and GII/14 tested were 103, 102, 103, 102, 103, 103, 103, 103, and 103 copies/tube, respectively. Thus, the sensitivity of the RT-LAMP assay was different depending on the genotype. Although the fecal specimens containing the genotypes GI/2, GI/11, and GII/5 used in this test also included other genotypes (GII/12, GII/3, and GI/14, respectively), these sensitivities were similar to the others. Furthermore, it was observed that none of the genogroup-specific primers cross-reacted between genogroups with any of the fecal specimens obtained from NoV outbreaks (Table 2).
![]() View larger version (72K): [in a new window] |
FIG. 2. Sensitivity of genogroup-specific RT-LAMP assay for standard RNAs of genotype GI/2 for genogroup I (A) and GII/12 for genogroup II (B). Lanes: M, 100-bp DNA ladder; 1, 104 copies/tube; 2, 103 copies/tube; 3, 102 copies/tube; 4, 101 copies/tube. Positive reaction shows a ladder-like pattern in 3% agarose gel electrophoresis. The turbidity was measured using an LA-320C (Teramecs), and RT-PCR was carried out with primers G1SKF and G2SKR for genogroup I and G2SKF and G2SKR for genogroup II (13). +, positive; , negative.
|
![]() View larger version (25K): [in a new window] |
FIG. 3. Evaluation of cross-reactivity of genogroup-specific RT-LAMP assay between genogroups I and II. Standard RNAs of genotypes GI/2 and GII/12 at 108 copies/tube were used in genogroups I and II, respectively. The real-time turbidity was determined using an LA-320C (Teramecs).
|
|
View this table: [in a new window] |
TABLE 2. Comparison of RT-PCR and RT-LAMP assays for detection of noroviruses in gastroenteritis outbreaks
|
Evaluation of RT-LAMP assay with fecal specimens. A total of 75 fecal specimens obtained from 26 NoV outbreaks were tested by the genogroup-specific RT-LAMP assay, and the results were compared to those of conventional RT-PCR. A concordance of 95% (71 of 75) between the RT-LAMP assay and RT-PCR was observed. Of the 75 samples, 23 and 57 were positive for GI and GII, respectively, and 48 and 18 were negative for GI and GII, respectively, in both assays. The RT-LAMP assay, however, gave positive results for four RT-PCR-negative specimens of two outbreaks and detected NoV GI in these specimens. These fecal specimens were also positive by the RT-LAMP assay in retests. The sensitivity and specificity of the RT-LAMP assay with regard to RT-PCR were 100 and 94% for GI and 100 and 100% for GII, respectively. Of 27 NoV-positive specimens in GI, 22 (81%) reacted within 60 min in the RT-LAMP assay and 50 (88%) of 57 positive specimens in GII reacted within 60 min (Table 2). The genotypes detected from the 26 NoV outbreaks were divided into six types (GI/1, GI/2, GI/4, GI/8, GI/11, and GI/14) for GI and nine types (GII/1, GII/2, GII/3, GII/4, GII/5, GII/6, GII/8, GII/12, and GII/14) for GII. The RT-LAMP assay was able to detect all of these genotypes of NoV with a high degree of specificity. The number of genome copies in the RT-LAMP-positive specimens was estimated to range from 1.7 x 102 to 3.7 x 108 copies/tube in GI and from 1.3 x 103 to 3.2 x106 copies/tube in GII (Table 3). The numbers of copies of NoV genomes in the fecal specimens obtained from gastroenteritis outbreaks in this study were higher than the levels of sensitivity of the RT-LAMP assay.
|
View this table: [in a new window] |
TABLE 3. Numbers of genome copies in RT-LAMP-positive fecal specimens, as determined by RT-PCR
|
|
|
|---|
We could achieve rapid detection of NoV genomes by using a one-step, single-tube genogroup-specific RT-LAMP assay. This is the first report of the development of an RT-LAMP assay for the detection of NoV genomes. The specificity of the RT-LAMP assay for NoV genomes was established by examining the cross-reaction with standard RNAs of GI and GII, RNA templates of 15 genotypes of NoVs, and RNAs of other viruses causing gastroenteritis. The RT-LAMP assay for the detection of NoV genomes was genogroup and genus specific and can be used for the detection of NoVs from outbreaks of food-borne and person-to-person-transmitted gastroenteritis and sporadic gastroenteritis cases.
At least 14 and 17 genotypes have been found for GI and GII, respectively (10). It is difficult to detect many genotypes using an RT-LAMP assay system with a high degree of sensitivity because of the diversity of NoV genotypes. Our RT-LAMP assay was able to detect NoV genomes with sensitivity levels of approximately 102 to 103 copies/tube in serial 10-fold dilution tests of RNA templates and had good performance with regard to concordance, specificity, and sensitivity in comparison to RT-PCR. Although the sensitivity of the RT-LAMP assay differed by genotype and was not influenced by the presence of multiple genotypes in a fecal specimen, our RT-LAMP assay was sufficient to detect NoV genomes from fecal specimens. However, it may be necessary to further lower the limit of detection because the numbers of copies of the NoV genome in foods such as oysters are low (17).
A total of 15 genotypes (GI/1, GI/2, GI/4, GI/8, GI/11, and GI/14 of GI and GII/1, GII/2, GII/3, GII/4, GII/5, GII/6, GII/8, GII/12, and GII/14 of GII) tested could be detected by our RT-LAMP assay. The sensitivity of the detection of the remaining 16 genotypes (GI/3, GI/5, GI/6, GI/7, GI/9, GI/10, GI/12, and GI/13 of GI and GII/7, GII/9, GII/10, GII/11, GII/13, GII/15, GII/16, and GII/17 of GII) by our RT-LAMP assay must be tested in further studies, although the primers used in the RT-LAMP assay were probably designed as consensus primers for the NoV sequences obtained from GenBank, and it is expected that the RT-LAMP assay will also be able to detect the remaining genotypes not tested in this study.
We expect that the genogroup-specific RT-LAMP assay will be routinely used in most laboratories because of its simplicity, specificity, and selectively. The greatest advantage of the RT-LAMP assay is the substantial reduction in required time compared to that required for RT-PCR. Our simple-to-use genogroup-specific RT-LAMP assay shortens the amplification time to within 90 min or even 60 min in most cases.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»